Poster Abstracts
Grand Hall CD (Manchester Grand Hyatt)
The Impact of Leukocyte Dose during Autologous Stem Cell Transplant on Lymphocyte Recovery in Lymphoma Patients
Amer Beitinjaneh, MD, MPH, MS, University of Virginia School of Medicine;
Beverly Turner, University of Virginia School of Medicine;
Leonid Volodin, MD, University of Virginia School of Medicine;
Tamila L Kindwall-Keller, DO, MS, University of Virginia School of Medicine;
Hannah E. Spencer, MSc, University of Virginia School of Medicine;
Rebeca Gonzalez, RN, University of Virginia School of Medicine;
Paige G. Williams, University of Virginia School of Medicine
Trends in Bloodstream Bacterial Infections and Resistance Patterns over the Past Decade in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
Alicia K Chang, MD, Columbia University;
Marc Foca, Columbia University;
Zhezhen Jin, PhD, Columbia University;
Virginia Laird, Columbia University;
Sharon Shwartz, Columbia;
Anya Levinson, Columbia University;
Monica Bhatia, MD, Columbia University;
Esra Karamehmet, Columbia University Medical Center;
James Garvin, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
Prakash Satwani, MD, Columbia University Medical Center
Monocyte Recovery at Day 100 Is Associated with Improved Survival in Multiple Myeloma Patients Who Undergo Allogeneic Hematopoietic Cell Transplantation
Binod Dhakal, MD, Medical College of Wisconsin;
Ruta Brazauskas, PhD, Medical College of Wisconsin;
Carlos Arce-lara, MD, Medical College of Wisconsin;
Parameswaran N. Hari, MD, MS, CIBMTR/Medical College of Wisconsin;
Marcelo C. Pasquini, MD, MS, CIBMTR and Medical College of Wisconsin;
Anita D'Souza, MD, Medical College of Wisconsin
Recovery of Circulating T-Follicular Helper Cells after Hematopoietic Stem Cell Transplantation
Edouard Forcade, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Steven Paula, Dana-Farber Cancer Institute, Harvard Medical School;
Kristen Cowens, Dana-Farber Cancer Institute, Harvard Medical School;
Marta Leal Bento, Dana-Farber Cancer Institute, Harvard Medical School;
Sarah Nikiforow, MD PhD, Dana-Farber Cancer Institute, Harvard Medical School;
John Koreth, MBBS, DPhil, Dana-Farber Cancer Institute, Harvard Medical School;
Corey S. Cutler, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Vincent T. Ho, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Philippe Armand, MD, PhD, Dana-Farber Cancer Institute, Harvard Medical School;
Edwin P. Alyea III, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Robert J. Soiffer, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Joseph H Antin, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Bruce R. Blazar, MD, University of Minnesota;
Jerome Ritz, MD, Dana-Farber Cancer Institute, Harvard Medical School
CD3/8 T-Cell Responses to CMV Reactivation and Association with Overall Survival in T-Cell Replete Haploidentical Transplants: A Retrospective Analysis
Mahasweta Gooptu, MD, Thomas Jefferson University Hospital;
Benjamin Leiby, Thomas Jefferson University;
Onder Alpdogan, MD, Thomas Jefferson University;
Matthew Carabasi, MD, Thomas Jefferson University;
Joanne Filicko, MD, Thomas Jefferson University Hospital;
Margaret Kasner, MD, Thomas Jefferson University;
Thomas Klumpp, MD, Thomas Jefferson University Hospital;
Ubaldo Martinez, MD, Kimmel Cancer Center, Thomas Jefferson University;
Barbara Pro, MD, Thomas Jefferson University;
Manish Sharma, MD, Thomas Jefferson University;
John L. Wagner, MD, Kimmel Cancer Center, Thomas Jefferson University;
Mark Weiss, MD, Thomas Jefferson University;
Neal Flomenberg, MD, Thomas Jefferson University;
Dolores Grosso, DNP, Thomas Jefferson University
Second Allogeneic Hematopoietic Cell Transplantation for Graft Failure: Poorer Outcomes for Neutropenic Graft Failure
Troy Christopher Lund, MD, PhD, University of Minnesota;
Jessica Liegel, MD, University of Minnesota;
Paul Orchard, MD, University of Minnesota Masonic Cancer Research Building;
Qing Cao, MS, University of Minnesota;
Jakub Tolar, MD, PhD, University of Minnesota;
Claudio G. Brunstein, MD, PhD, University of Minnesota Medical Center;
John E. Wagner, MD, University of Minnesota;
Michael R. Verneris, MD, University of Minnesota Medical Center, Fairview;
Daniel J. Weisdorf, MD, University of Minnesota Medical Center
Prolonged Stimulation-Induced Pro-Apoptotic B Cells and Deficits in the Germinal Center Formation of Memory B Cells within One Year after Allogeneic HSCT
Angela Mensen, PhD, Charité - Universitätsmedizin Berlin;
Youngseong Oh, Charité - Universitätsmedizin Berlin;
Philipp Hemmati, MD, Charité - Universitätsmedizin Berlin;
Christian Jehn, MD, Charité - Universitätsmedizin Berlin;
Jörg Westermann, MD, Charité - Universitätsmedizin Berlin;
Lam Vuong, PhD, Charité - Universitätsmedizin Berlin;
Bernd Dörken, MD, Max Delbrück Center (MDC) for Molecular Medicine;
Carmen Scheibenbogen, MD, Charité - Universitätsmedizin Berlin;
Renate Arnold, MD, Charité - Universitätsmedizin Berlin;
Il-Kang Na, MD, Charité - Universitätsmedizin Berlin
Immune Recovery (IR) Following Allogeneic Stem Cell Transplant (Allo-SCT): A Comparison of Three Different Transplant Strategies at a Single Transplant Center
Zeina Al-Mansour, MD, University of Massachusetts;
Mridula George, MD, UMass Medical Center;
Zheng Zhou, University of Massachusetts;
Glen Raffel, MD, PhD, UMass Medical Center;
Laura Petrillo-Deluca, PAC, UMass Memorial Medical Center;
Lindsey Shanahan, PAC, UMass Memorial Medical Center;
Hongbo Yu, MD, PhD, University of Massachusetts;
Bruce A Woda, MD, University of Massachusetts;
Muthalagu Ramanathan, MD, UMASS Memorial University Campus;
Jan Cerny, MD, PhD, FACP, University of Massachusetts;
Rajneesh Nath, MD, University of Massachusetts
Prognostic Value of IL-7 and SCF Levels on Thymic Reconstitution and Clinical Outcomes after Double Umbilical Cord Transplantation in Adults
Ioannis Politikos, MD, Beth Israel Deaconess Medical Center, Harvard Medical School;
Haesook T. Kim, PhD, Dana-Farber Cancer Institute;
Sarah Nikiforow, MD PhD, Dana-Farber Cancer Institute, Harvard Medical School;
Lequn Li, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School;
Karen K. Ballen, MD, Massachusetts General Hospital;
Joseph H. Antin, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Jerome Ritz, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Corey S. Cutler, MD, Dana-Farber Cancer Institute, Harvard Medical School;
Vassiliki A. Boussiotis, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School
Chimerism, Immune Reconstitution and Outcome after Allogeneic Myeloablative and Reduced Intensity Unrelated and Haploidentical PBSC Transplantation Using Post-Transplant Cyclophosphamide
Ayman Saad, MD,, University of Alabama at Birmingham - UAB;
Racquel Innis-Shelton, MD, University of Alabama at Birmingham;
Donna Salzman, MD, The University of Alabama at Birmingham;
Luciano J. Costa, MD, PhD, University of Alabama at Birmingham;
Antonio di Stasi, MD, University of Alabama at Birmingham;
Ravikumar Paluri, MD, University of Alabama at Birmingham;
Melissa Gazi, University of Alabama at Birmingham;
Lisa Williams, RN, University of Alabama / Birmingham;
John Townsend, University of Alabama at Birmingham;
Vera Hauptfeld, University of Alabama at Birmingham;
Lawrence Lamb, PhD, University of Alabama at Birmingham;
Shin Mineishi, MD, University of Alabama at Birmingham
Dynamical System Modeling of Immune Reconsitution Following Allogeneic Stem Cell Transplantation (SCT) Conditioned with Rabbit Anti-Thymocyte Globulin
Amir Ahmed Toor, MD, VCU Massey Cancer Center;
Roy Sabo, PhD, Virginia Commonwealth University;
Salman R Salman, Virginia Commonwealth University;
Bonny Moore, MD, VCU Medical Center;
Allison F Scalora, MS, VCU Massey Cancer Center;
May Aziz, PharmD, Virginia Commonwealth University;
Jared Kobulnicky, MD, VCU Medical Center;
Jeremy A Meier, BS, Virginia Commonwealth University;
Ali S Shubar Ali, BS, Virginia Commonwealth University;
Masoud Manjili, PhD, VCU Massey Cancer Center;
Shiyu Song, MD, VCU Medical Center;
William Clark, MD, MS, VCU Massey Cancer Center;
John Michael McCarty, MD, VCU Massey Cancer Center;
Michael C Neale, PhD, VCU;
Harold Chung, MD, VCU Massey Cancer Center;
Catherine H. Roberts, PhD, VCU Massey Cancer Center
Adoptive T-Cell Therapy to Prevent and Treat Human Metapneumovirus (hMPV) Infections Post Hematopoietic Stem Cell Transplant (HSCT)
Ifigenia Tzannou, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Sarah K Nicholas, MD, Baylor College of Medicine, Texas Children's Hospital;
Anisha Misra, Baylor College of Medicine;
Usha L Katari, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Jordan Orange, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Juan F. Vera, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Cliona M. Rooney, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital;
Ann M. Leen, PhD, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital
![[Visit Client Website]](images/banner.gif)